Safety and Efficacy of Autologous Stem Cell Treatment for Facetogenic Chronic Back Pain.

J Pers Med · 2023 · PMC10058908 · PMID 36983621

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep = 0.05actually significant

The difference in mean cell diameter between Transpose RT/no Matrase-isolated ADRCs (10.2 μm ± 0.1 μm) and Transpose RT/Matrase-isolated ADRCs (10.6 μm ± 0.1 μm) was only approximately 4% and did not reach statistical significance ( p = 0.05; n = 12 matched pairs of samples).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.